A Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

116.000

Open

115.810

VWAP

113.51

Vol

896.51K

Mkt Cap

32.67B

Low

111.930

Amount

101.76M

EV/EBITDA(TTM)

18.63

Total Shares

282.60M

EV

34.27B

EV/OCF(TTM)

24.55

P/S(TTM)

4.66

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.

Show More

Events Timeline

(ET)

2026-05-04

08:20:00

Agilent Appoints Michael Buckner as Chief Legal Officer

2026-04-22 (ET)

2026-04-22

07:10:00

Labcorp Launches Agilent PD-L1 Test Nationwide

2026-04-01 (ET)

2026-04-01

08:11:00

Agilent Launches BioTek Cytation 9 Multimode Cell Imaging Reader

2026-03-26 (ET)

2026-03-26

08:10:00

Agilent Receives FDA Approval for PD-L1 IHC 22C3 as KEYTRUDA Companion Diagnostic

2026-03-23 (ET)

2026-03-23

08:20:00

MaxCyte Appoints Parmeet Ahuja as CFO

News

Newsfilter

04-22Newsfilter

Virtus and Lloyds Plan to Restart Chemaf Production

CNBC

Vertex Pharmaceuticals Stock Performance Strong

Yahoo Finance

04-01Yahoo Finance

Synthego Welcomes Supreme Court Ruling Finalizing Invalidation of Agilent CRISPR Patents

Marketbeat

03-29Marketbeat

The Overlooked Sector of Healthcare That Has Captivated Wall Street

NASDAQ.COM

03-26NASDAQ.COM

Agilent Receives FDA Approval for New Diagnostic Tool

Newsfilter

03-26Newsfilter

Agilent Receives FDA Approval for New Diagnostic Tool

13 Analyst Rating

Wall Street analysts forecast A stock price to rise

12 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

160.00

Averages

171.67

High

180.00

Current: 0.000

Low

160.00

Averages

171.67

High

180.00

Barclays

Luke Sergott

Overweight

downgrade

$150 -> $140

AI Analysis

2026-04-14

Reason

Barclays

Luke Sergott

Price Target

$150 -> $140

AI Analysis

2026-04-14

downgrade

Overweight

Reason

Barclays analyst Luke Sergott lowered the firm's price target on Agilent to $140 from $150 and keeps an Overweight rating on the shares. The firm adjusted targets in the life science and diagnostic tools group as part of a Q1 preview. Barclays likes the setup for the sector but says it is "not without risk." Sentiment is at all-time lows and Barclays still believes in the "last-cut thesis (for the most part)," the analyst tells investors in a research note.

Evercore ISI

Outperform

to

Outperform

downgrade

$160 -> $140

2026-04-06

Reason

Evercore ISI

Price Target

$160 -> $140

2026-04-06

downgrade

Outperform

to

Outperform

Reason

Evercore ISI lowered the firm's price target on Agilent to $140 from $160 and keeps an Outperform rating on the shares as part of the firm's medical technology and life science tools Q1 preview.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for A

Unlock Now

Valuation Metrics

The current forward P/E ratio for Agilent Technologies Inc (A.N) is 19.80, compared to its 5-year average forward P/E of 25.10. For a more detailed relative valuation and DCF analysis to assess Agilent Technologies Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

25.10

Current PE

19.80

Overvalued PE

29.19

Undervalued PE

21.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

20.39

Current EV/EBITDA

16.92

Overvalued EV/EBITDA

23.47

Undervalued EV/EBITDA

17.30

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

5.70

Current PS

4.28

Overvalued PS

6.53

Undervalued PS

4.88

Financials

AI Analysis

Annual

Quarterly

Whales Holding A

Walleye Capital LLC

Argenta Asset Management SA

Harvest Portfolios Group Inc.

Schonfeld Strategic Advisors LLC

Qube Research & Technologies Ltd

Trading Trends

People Also Watch

Frequently Asked Questions

What is Agilent Technologies Inc (A) stock price today?

The current price of A is 112.59 USD — it has decreased -2.62

What is Agilent Technologies Inc (A)'s business?

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.

What is the price predicton of A Stock?

Wall Street analysts forecast A stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for A is171.67 USD with a low forecast of 160.00 USD and a high forecast of 180.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Agilent Technologies Inc (A)'s revenue for the last quarter?

Agilent Technologies Inc revenue for the last quarter amounts to 1.80B USD, increased 6.96

What is Agilent Technologies Inc (A)'s earnings per share (EPS) for the last quarter?

Agilent Technologies Inc. EPS for the last quarter amounts to 1.07 USD, decreased -3.60

How many employees does Agilent Technologies Inc (A). have?

Agilent Technologies Inc (A) has 18100 emplpoyees as of May 11 2026.

What is Agilent Technologies Inc (A) market cap?

Today A has the market capitalization of 32.67B USD.